Skip to main content
. 2022 May 17;13:888660. doi: 10.3389/fphar.2022.888660

FIGURE 3.

FIGURE 3

Relationship between peak plasma rivaroxaban level and (A) eGFR and (B) stage of CKD in patients receiving rivaroxaban 15 mg once daily.